Accretion Nutraveda AGM resolutions pass with unanimous shareholder support

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Accretion Nutraveda shareholders unanimously approved all 10 resolutions at its 5th AGM
  • Standalone financial statements for FY26 were adopted with 5.32 million votes in favor
  • Two new independent directors, Chand Kanabar and Grishma Shewale, were appointed
  • Remuneration revisions for six key executives received 100% shareholder support
powered bylight_fuzz_icon
49394847

*this image is generated using AI for illustrative purposes only.

Accretion Nutraveda Limited declared the voting results for its fifth annual general meeting held on August 27, 2026. Shareholders unanimously approved all ten resolutions proposed at the gathering.

The meeting, conducted via video conferencing, saw shareholders adopt the standalone financial statements for FY26 and approve key board changes. The scrutinizer report confirmed that all resolutions received 100% of the votes cast in their favor, with no votes against or invalid votes recorded.

Voting Results Overview

The remote e-voting facility was open from August 24 to August 26, 2026. Members who did not vote remotely were given a window to cast electronic votes during the meeting. Mr. Nimish Chunibhai Sakhya served as the scrutinizer for the process.

The consolidated results for the key resolutions are detailed below:

Resolution Type Key Outcome Votes in Favor % Support
Ordinary Adoption of FY26 Financial Statements 5,322,000 100%
Ordinary Reappointment of Vivek Ashokkumar Patel 4,524,000 100%
Special Appointment of Chand Rameshbhai Kanabar (Ind. Dir.) 5,322,000 100%
Special Appointment of Grishma A Shewale (Ind. Dir.) 5,322,000 100%
Special Remuneration Revision for Managing Director 4,524,000 100%

Board and Governance Updates

Shareholders approved the reappointment of Mr. Vivek Ashokkumar Patel as a director retiring by rotation. Additionally, the company secured approval for the appointment of two new independent directors: Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale.

The Board also obtained unanimous approval for revised remuneration packages for several key executives. These revisions covered:

  • Mr. Mayur Popatlal Sojitra (Managing Director)
  • Mr. Paraskumar Vinubhai Parmar (CFO and Director)
  • Mr. Ankurkumar Shantilal Patel (Whole-Time Director)
  • Mr. Harshad Nanubhai Rathod (Director)
  • Mr. Vivek Ashokkumar Patel (Director)
  • Mr. Hardik Mukundbhai Prajapati (Director)

Audit and Compliance

The statutory auditor, CA Dr. Vishves Shah, and secretarial auditor, Mr. Nimish Sakhija, were present at the meeting. The audit reports for the year ended March 31, 2026, contained no qualifications or adverse observations. Consequently, these reports were not read out during the meeting, adhering to standard procedural requirements under the Companies Act, 2013.

Mr. Harshad Rathod, Chairman and Director, presided over the proceedings, which commenced at 2:00 pm and concluded at 2:18 pm.

Historical Stock Returns for Accretion Nutraveda

1 Day5 Days1 Month6 Months1 Year5 Years
-0.27%-0.98%0.0%0.0%0.0%0.0%

How will the appointment of new independent directors Chand Rameshbhai Kanabar and Grishma A Shewale influence Accretion Nutraveda's strategic direction and corporate governance standards?

What specific performance metrics or growth targets are likely tied to the revised remuneration packages approved for the Managing Director and other key executives?

Given the unanimous approval of FY26 financials, what are the projected revenue growth and margin expansion targets for Accretion Nutraveda in the upcoming fiscal year?

Accretion Nutraveda to seek approval for director appointments, pay hikes at AGM

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Accretion Nutraveda Limited's 5th AGM on August 27, 2026, focuses on governance updates, including the appointment of two independent directors and remuneration revisions for six key executives. Shareholders will also adopt FY26 financials showing ₹3,360.31 lakh revenue.

powered bylight_fuzz_icon
47124768

*this image is generated using AI for illustrative purposes only.

Accretion Nutraveda Limited will hold its 5th Annual General Meeting (AGM) on Thursday, August 27, 2026, via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting, scheduled to begin at 02:00 P.M. IST, is critical for shareholders as they will vote on the appointment of two new independent directors and approve significant remuneration revisions for six existing directors. This governance update follows the company’s strong financial performance in FY26, where it reported a revenue from operations of ₹3,360.31 lakh and a profit after tax of ₹506.83 lakh.

The agenda includes ordinary business items such as the adoption of standalone financial statements for the year ended March 31, 2026, and the re-appointment of Mr. Vivek Ashokkumar Patel, who retires by rotation. Under special business, shareholders are asked to pass resolutions for the appointment of Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale as Non-Executive Independent Directors. Both were initially appointed as Additional Directors by the Board on May 8, 2026, and will serve five-year terms until May 7, 2031.

Remuneration Revisions

A major focus of the AGM is the revision of remuneration for six directors, effective for three years from the 5th AGM to the 8th AGM. The Nomination and Remuneration Committee recommended these changes, citing the need to align compensation with industry standards and individual qualifications. All six directors will be entitled to a monthly salary of up to ₹5,00,000, along with perquisites including group medical insurance, personal accident insurance, and provident fund contributions.

Director Name Designation Current Remuneration (₹) Proposed Monthly Salary Cap (₹)
Mayur Popatlal Sojitra Managing Director 8,93,100 5,00,000
Paraskumar Vinubhai Parmar Executive Director & CFO 13,10,600 5,00,000
Ankurkumar Shantilal Patel Whole-Time Director 13,10,600 5,00,000
Harshad Nanubhai Rathod Non-Executive Director 6,30,200 5,00,000
Vivek Ashokkumar Patel Non-Executive Director 6,30,200 5,00,000
Hardik Mukundbhai Prajapati Non-Executive Director 8,93,100 5,00,000

Note: Current remuneration figures represent annual amounts as disclosed in Annexure C. The proposed salary is a monthly cap.

Governance and Compliance

The appointment of Mr. Chand Rameshbhai Kanabar brings expertise in business development and financial strategy, while Ms. Grishma A Shewale contributes over nine years of experience in corporate law and SEBI compliance. The Board stated that their association would benefit the company’s strategic direction. The meeting adheres to MCA Circulars No. 20/2020 and subsequent updates, allowing remote participation without physical presence. Proxies are not permitted for this AGM, though body corporates may appoint authorized representatives.

What the Numbers Show

The remuneration structure highlights a shift towards standardized monthly caps for all executive and non-executive directors, despite varying current annual payouts. For instance, CFO Paraskumar Vinubhai Parmar and WTD Ankurkumar Shantilal Patel currently draw significantly higher annual remuneration (₹13.10 lakh each) compared to the proposed monthly cap of ₹5 lakh (₹60 lakh annually), suggesting the cap allows for additional variable components or incentives not explicitly detailed in the base salary resolution. The company’s FY26 profitability provides a solid foundation for these ongoing governance adjustments.

Historical Stock Returns for Accretion Nutraveda

1 Day5 Days1 Month6 Months1 Year5 Years
-0.27%-0.98%0.0%0.0%0.0%0.0%

How will the standardized ₹5 lakh monthly salary cap impact the retention of key executives like the CFO and WTD, whose current annual payouts significantly exceed this new base limit?

What specific strategic initiatives are the newly appointed independent directors, Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale, expected to drive in their first year to leverage their expertise in financial strategy and SEBI compliance?

Given the shift to a capped monthly salary structure, what variable performance metrics or incentive schemes will Accretion Nutraveda implement to ensure executive compensation remains competitive with industry standards?

More News on Accretion Nutraveda

1 Year Returns:0.00%